Editor-in-Chief
Full Professor Former Dean
Faculty of Medical Dentistry
Apollonia University of Iasi
Romania
Editor-in-Chief
Assistant Professor of Molecular Genetics and Biochemistry
Department of Molecular Genetics and Biochemistry
German International University
Egypt
Editor-in-Chief
Associate Professor Internal Medicine
DiMI Department of Internal Medicine
University of Genova
Italy
Editor-Member
Associate Professor
Henan Key Laboratory of Childrens Genetics and Metabolic Diseases
Zhengzhou University
China
Editor-Member
Assistant Research Fellow
School of Pharmacy
Shanghai Jiao Tong University
China
Editor-Member
Professor Consultant of Molecular Diagnostics and Medical Biotechnology
Medical Biotechnology
King Abdulaziz University (KAU)
Saudi Arabia
Editor-Member
Group Leader - Signal Transduction Unit
Department of Molecular Medicine and Surgery
Karolinska Institute
Sweden
Editor-Member
Department of Diagnostic and Therapeutic Technologies
Instituto Politécnico de Bragança
Portugal
Editor-Member
Faculty of Pharmacy
Faculty of Pharmacy, Minia University
King Khalid University
Egypt
Editor-Member
Associate Professor
Department of Pharmacy DIFAR
University of Genoa (UniGe), Italy
Italy
Editor-Member
Associate Professor
Faculty of Pharmacy
Odisha University of Health Sciences,Berhampur, Odisha
India
Editor-Member
PhD Researcher
Department of Analytical Chemistry
Faculty of Science, Tanta University
Egypt
Editor-Member
Professor
Faculty of Pharmacy
University of Medicine, Pharmacy, Science and Technology of Targu Mures
Romania
The Journal of Pharma and Drug Innovation (JPDI) is an international, peer-reviewed, open-access journal that publishes high-quality research in pharmaceutical sciences and drug development.
The journal provides a platform for researchers, academicians, pharmacists, and healthcare professionals to share scientific findings and advancements in areas related to drug discovery, development, and therapeutic applications. It supports the dissemination of research that contributes to both fundamental understanding and applied aspects of pharmaceutical sciences.
JPDI covers a broad range of topics including pharmacology, pharmaceutics, pharmacognosy, medicinal chemistry, drug design and delivery, pharmaceutical biotechnology, regulatory science, toxicology, and clinical pharmacy. The journal also encourages interdisciplinary research integrating pharmacy, medicine, chemistry, and life sciences.
The journal publishes original research articles, review articles, short communications, and case studies. All submissions undergo an initial editorial assessment followed by a rigorous peer review process to ensure scientific quality, originality, and relevance.
JPDI operates under an open access model, providing unrestricted access to published content to support the global dissemination of scientific knowledge and research.
Authors may submit their manuscripts through the online Submit Manuscript system or by sending their manuscript as an e-mail attachment to the Editorial Office at editorialoffice@confseries.net.
Editorial and Publication Process
JPDI is committed to maintaining an efficient, transparent, and quality-focused editorial workflow that support the dissemination of scholarly research.
The journal aims to provide authors with a transparent and structured publication process while ensuring that all submissions undergo appropriate editorial assessment and peer review procedures. Editorial timelines may vary depending on the scope of the manuscript, reviewer availability, revision requirements, and the overall review process.
Submitted manuscripts proceed through the journal's standard editorial and publication workflow, which includes editorial screening, peer review, revisions (where required), copyediting, and final publication.
All submissions are evaluated based on scientific quality, originality, ethical compliance, and relevance to the journal's scope. The editorial process is designed to maintain academic integrity and ensure consistency in publication standards.
Accepted manuscripts proceed through the production stage, including copyediting, formatting, proof review, final author approval, and online publication.
Authors retain the copyright of their published work, and final articles are made available through the journal's open-access publishing model to support global accessibility and scholarly communication.
The editorial team is committed to upholding recognized scholarly publishing practices while maintaining fairness, transparency, and ethical standards throughout the editorial and publication process.
The journal follows a structured editorial and peer-review process designed to ensure academic quality, ethical integrity, and a transparent publication process. Each manuscript progresses through clearly defined stages, as illustrated in the workflow below.
Manuscript Submission
Authors submit their manuscripts through the Confseries submission platform. All submissions must
comply with the journal's scope, author instructions, and ethical standards.
Editorial Office Initial Check
Each new submission undergoes an initial assessment by the editorial office to confirm:
Manuscripts identified as containing substantial plagiarism, duplicate submission, or serious ethical concerns are rejected during the initial editorial assessment without external peer review.
Manuscripts meeting the journal's initial editorial requirements proceed to the peer-review stage.
After passing the initial screening:
Reviewer Assessment
Reviewers critically evaluate each manuscript based on:
Editorial Decision
Based on reviewer feedback and editorial evaluation, one of the following decisions is issued:
Revision and Re-evaluation
For manuscripts requiring revision:
Acceptance and Publication
Manuscripts accepted for publication proceed to the production phase, which includes:
Ethical and Editorial Integrity
The journal's peer-review workflow reflects a transparent, ethical, and structured editorial process, ensuring that every manuscript is evaluated fairly, objectively, and on its scientific merit before publication.
